Healthcare provider profile · identity verified

Ali M Yahya, MD

Internal Medicine · ROANOKE, VA · NPI 1013934181

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	389	82
Eliquis	Apixaban	273	39
Amlodipine Besylate	Amlodipine Besylate	262	59
Gabapentin	Gabapentin	206	41
Metoprolol Tartrate	Metoprolol Tartrate	165	39
Levothyroxine Sodium	Levothyroxine Sodium	159	29
Levetiracetam	Levetiracetam	141	19
Mirtazapine	Mirtazapine	109	26
Tamsulosin Hcl	Tamsulosin Hcl	100	24
Lisinopril	Lisinopril	98	23
Metformin Hcl	Metformin Hcl	97	20
Losartan Potassium	Losartan Potassium	92	27
Clopidogrel	Clopidogrel Bisulfate	91	19
Escitalopram Oxalate	Escitalopram Oxalate	86	15
Furosemide	Furosemide	85	28
Famotidine	Famotidine	84	19
Methenamine Hippurate	Methenamine Hippurate	80	suppressed
Donepezil Hcl	Donepezil Hcl	75	13
Divalproex Sodium	Divalproex Sodium	73	21
Januvia	Sitagliptin Phosphate	71	suppressed
Omeprazole	Omeprazole	68	17
Quetiapine Fumarate	Quetiapine Fumarate	68	17
Hydralazine Hcl	Hydralazine Hcl	67	20
Jardiance	Empagliflozin	67	suppressed
Trazodone Hcl	Trazodone Hcl	67	24
Latanoprost	Latanoprost	63	15
Nifedipine Er	Nifedipine	62	13
Duloxetine Hcl	Duloxetine Hcl	60	17
Hydrochlorothiazide	Hydrochlorothiazide	58	11
Xarelto	Rivaroxaban	58	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	57	24
Potassium Chloride	Potassium Chloride	56	18
Tivicay	Dolutegravir Sodium	56	suppressed
Sertraline Hcl	Sertraline Hcl	55	13
Pravastatin Sodium	Pravastatin Sodium	52	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	49	suppressed
Memantine Hcl	Memantine Hcl	48	suppressed
Risperidone	Risperidone	45	12
Tresiba Flextouch U-200	Insulin Degludec	45	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Enulose	Lactulose	40	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	21
Lactulose	Lactulose	35	11
Gemtesa	Vibegron	34	suppressed
Metoprolol Succinate	Metoprolol Succinate	34	16
Baclofen	Baclofen	33	suppressed
Lyumjev Kwikpen U-100	Insulin Lispro-Aabc	33	suppressed
Insulin Aspart Flexpen	Insulin Aspart	32	suppressed
Benztropine Mesylate	Benztropine Mesylate	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	14
Olanzapine	Olanzapine	31	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	30	suppressed
Oxycodone Hcl	Oxycodone Hcl	30	18
Buspirone Hcl	Buspirone Hcl	29	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	28	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	28	suppressed
Trulicity	Dulaglutide	28	suppressed
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	17
Scopolamine	Scopolamine	26	suppressed
Nuplazid	Pimavanserin Tartrate	25	suppressed
Warfarin Sodium	Warfarin Sodium	23	suppressed
Incruse Ellipta	Umeclidinium Bromide	22	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	21	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	21	suppressed
Lubiprostone	Lubiprostone	21	suppressed
Midodrine Hcl	Midodrine Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Tradjenta	Linagliptin	21	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	16
Novolog Flexpen	Insulin Aspart	20	suppressed
Simvastatin	Simvastatin	20	suppressed
Travoprost	Travoprost	20	suppressed
Lacosamide	Lacosamide	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	19	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Carvedilol	Carvedilol	17	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Heparin Sodium	Heparin Sodium,porcine	17	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	17	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	17	suppressed
Tramadol Hcl	Tramadol Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	suppressed
Desmopressin Acetate	Desmopressin Acetate	16	suppressed
Entacapone	Entacapone	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Levofloxacin	Levofloxacin	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Lorazepam	Lorazepam	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Constulose	Lactulose	14	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Ceftriaxone	Ceftriaxone Sodium	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Atropine Sulfate	Atropine Sulfate	12	suppressed
Bromocriptine Mesylate	Bromocriptine Mesylate	12	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	12	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	12	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Fluticasone Propionate	Fluticasone Propionate	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Olanzapine Odt	Olanzapine	12	suppressed
Prezcobix	Darunavir/Cobicistat	12	suppressed
Carbamazepine	Carbamazepine	11	suppressed
Dextrose In Water	Dextrose 5 % In Water	11	suppressed
Meropenem	Meropenem	11	suppressed
Nyamyc	Nystatin	11	suppressed
Prednisone	Prednisone	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed
Sodium Chloride	Sodium Chloride 0.45 %	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Sucralfate	Sucralfate	11	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error